Home » Topics » Regulatory

Regulatory
RSS

Mylan Laboratories's Acyclovir receives FDA approval

April 25, 1997

Final FDA approval for Faulding's acyclovir injection

April 24, 1997

IVAX presents promising preclinical results with Elmiron

April 22, 1997

Teva receives FDA approval for antihypertensive generic

April 22, 1997

U.K. approval for Edronax

April 21, 1997

Imitrex Nasal Spray introduced in Canada

April 21, 1997

Royce Laboratories' generic antiinflammatory approved by FDA

April 18, 1997

Biovail's Tiazac approved and introduced in Canada

April 17, 1997

Supplemental BLA submitted in U.S. for Proleukin

April 16, 1997

Another minoxidil generic approved in U.S. for women

April 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.